| Genmab A/S | 2,226.00 |
| Date/Time | 05/11 / 13:07 |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | 2,258.00 |
| Previous Close | 2,287.50 |
| High | 2,258.00 |
| Low | 2,216.50 |
| Volume [DKK] | 1,622,316.50 |
| Volume [Units] | 725 |
| Price fixings | 26 |
| ISIN | DK0010272202 |
| Security | GMAB/C |
| Exchange | Cboe Europe BXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 297.300 |  |
193 |
| Nasdaq Other.. | 372.7200 |  |
174 |
| Vienna Globa.. | 300.60 | |
0 |
| München | 305.60 | |
0 |
| Düsseldorf | 299.00 | |
0 |
| Frankfurt | 297.2000 |  |
0 |
| Berlin | 300.70 | |
0 |
| Stuttgart | 299.100 | |
0 |
| London Inter.. | 2,229.0 | |
|
| Lang & Schwa.. | 299.60 | |
|
| gettex | 299.700 | |
|
| OMX Nordic | 2,231.00 | |
139,142 |
| Cboe Europe .. | 2,230.00 | 26,191 | |
| Turquoise | 2,231.00 | |
8,762 |
| Cboe Europe .. | 2,252.00 | 4 | |
| Cboe Europe .. | 2,226.00 | 725 | |
| Mexico | 7,638.15 | |
11,330 |
News
- Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
05/11/2021 / 08:30 - GlobeNewswire - BioNTech Announces First Quarter 2021 Financial Results and Corporate Update
05/10/2021 / 13:00 - GlobeNewswire - BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore
05/10/2021 / 07:31 - GlobeNewswire - Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
05/07/2021 / 12:45 - GlobeNewswire - Merus Announces Financial Results for the First Quarter and Provides Business Update
05/06/2021 / 23:14 - GlobeNewswire
Real-time